By Li Zhongsheng and Song Xinyue King & Wood Mallesons’ IP group.
In January 2017, Beijing Sihuan Pharmaceutical Co., Ltd. (“Sihuan Pharm”), represented by a King & Wood Mallesons’ IP litigation team, succeeded in a patent infringement trial. The Inner Mongolia Hohhot Intermediate People’s Court (the “Court”) found that Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) had infringed two of Sihuan Pharm’s patents, and ordered Qilu Pharmaceutical to cease the infringement. The case involves standard-related patents in the pharmaceutical sector and drew lots of attention in the industry. The Court’s decision is a valuable precedent for the judicial protection of pharmaceutical patents.
Read full article, please click here.